Log in

OTCMKTS:RSPI - Respirerx Pharmaceuticals Stock Price, Forecast & News

0.00 (0.00 %)
(As of 12/8/2019 03:20 AM ET)
Today's Range
Now: $0.23
50-Day Range
MA: $0.25
52-Week Range
Now: $0.23
Volume5,327 shs
Average Volume2,752 shs
Market Capitalization$946,530.00
P/E RatioN/A
Dividend YieldN/A
RespireRx Pharmaceuticals Inc. engages in the discovery and development of pharmaceuticals for the treatment of respiratory disorders. The company has two drug platforms comprising ampakines that act to enhance the actions of the excitatory neurotransmitter glutamate at AMPA glutamate receptors; and cannabinoids, primarily dronabinol, a synthetic derivative for use in refractory chemotherapy-induced nausea and vomiting, as well as for anorexia in patients with AIDS. It develops various ampakines in oral and injectable form for the treatment of various breathing disorders. The company's lead ampakine, CX1739, which is in Phase II clinical studies for drug-induced respiratory depression (RD), as well as for central sleep apnea. It is also developing CX717, CX1739, and CX1942 that have clinical application in the treatment of CNS-driven respiratory disorders, neurobehavioral disorders, spinal cord injury, neurological diseases, and orphan indications. The company was formerly known as Cortex Pharmaceuticals, Inc. and changed its name to RespireRx Pharmaceuticals Inc. in December 2015. RespireRx Pharmaceuticals Inc. was founded in 1987 and is based in Glen Rock, New Jersey.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:RSPI



Sales & Book Value

Annual SalesN/A
Book Value($1.60) per share


Net Income$-2,590,000.00


Market Cap$946,530.00
Next Earnings Date4/21/2020 (Estimated)
OptionableNot Optionable

Receive RSPI News and Ratings via Email

Sign-up to receive the latest news and ratings for RSPI and its competitors with MarketBeat's FREE daily newsletter.

Respirerx Pharmaceuticals (OTCMKTS:RSPI) Frequently Asked Questions

What is Respirerx Pharmaceuticals' stock symbol?

Respirerx Pharmaceuticals trades on the OTCMKTS under the ticker symbol "RSPI."

How were Respirerx Pharmaceuticals' earnings last quarter?

Respirerx Pharmaceuticals Inc (OTCMKTS:RSPI) posted its quarterly earnings data on Monday, November, 20th. The company reported ($0.27) earnings per share for the quarter. View Respirerx Pharmaceuticals' Earnings History.

When is Respirerx Pharmaceuticals' next earnings date?

Respirerx Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Tuesday, April 21st 2020. View Earnings Estimates for Respirerx Pharmaceuticals.

Has Respirerx Pharmaceuticals been receiving favorable news coverage?

News stories about RSPI stock have trended somewhat positive on Sunday, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Respirerx Pharmaceuticals earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 8.0 out of 10, meaning that recent media coverage is very likely to have an effect on the company's share price in the next several days. View News Stories for Respirerx Pharmaceuticals.

Who are some of Respirerx Pharmaceuticals' key competitors?

What other stocks do shareholders of Respirerx Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Respirerx Pharmaceuticals investors own include FuelCell Energy (FCEL) and Ballard Power Systems (BLDP).

Who are Respirerx Pharmaceuticals' key executives?

Respirerx Pharmaceuticals' management team includes the folowing people:
  • Dr. Arnold S. Lippa, Exec. Chairman, Interim Pres, Interim CEO & Chief Scientific Officer (Age 72)
  • Dr. Jeff Eliot Margolis, Sr. VP, CFO, Treasurer, Sec. & Director (Age 63)
  • Mr. Richard D. Purcell, Sr. VP of R&D (Age 58)
  • Mr. Marc M. Radin, Controller
  • Dr. Arvid Carlsson M.D., Ph.D., Consultant (Age 96)

How do I buy shares of Respirerx Pharmaceuticals?

Shares of RSPI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Respirerx Pharmaceuticals' stock price today?

One share of RSPI stock can currently be purchased for approximately $0.23.

How big of a company is Respirerx Pharmaceuticals?

Respirerx Pharmaceuticals has a market capitalization of $946,530.00. Respirerx Pharmaceuticals employs 2 workers across the globe.View Additional Information About Respirerx Pharmaceuticals.

What is Respirerx Pharmaceuticals' official website?

The official website for Respirerx Pharmaceuticals is http://www.respirerx.com/.

How can I contact Respirerx Pharmaceuticals?

Respirerx Pharmaceuticals' mailing address is 126 VALLEY ROAD SUITE C, GLEN ROCK NJ, 07452. The company can be reached via phone at 201-444-4947 or via email at [email protected]

MarketBeat Community Rating for Respirerx Pharmaceuticals (OTCMKTS RSPI)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  41 (Vote Outperform)
Underperform Votes:  44 (Vote Underperform)
Total Votes:  85
MarketBeat's community ratings are surveys of what our community members think about Respirerx Pharmaceuticals and other stocks. Vote "Outperform" if you believe RSPI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RSPI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel